Maxcyte (MXCT) Asset Utilization Ratio (2021 - 2026)

Maxcyte (MXCT) has 6 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.09, down 24.77% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.09 (down 24.77% YoY), and the FY2025 annual result was 0.09, down 37.67% from the prior year.
• Asset Utilization Ratio improved to 0.09 in Q1 2026 per MXCT's latest filing, from 0.07 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.13 in Q2 2025 and troughed at 0.06 in Q3 2023.
• A 5-year average of 0.09 and a median of 0.09 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 67.48% in 2022, then plunged 41.66% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.09 in 2022, then decreased by 2.8% to 0.09 in 2023, then soared by 31.07% to 0.11 in 2024, then sank by 41.66% to 0.07 in 2025, then jumped by 34.84% to 0.09 in 2026.
• Business Quant data shows MXCT's Asset Utilization Ratio at 0.09 in Q1 2026, 0.07 in Q4 2025, and 0.13 in Q3 2025.